CDC panel supports Moderna’s two-dose COVID vaccine for children

on Immunization Practices (ACIP) on Thursday for use in children between the ages of 6 and 17.

Rochelle Walensky, the head of the CDC, is almost certain to endorse the committee’s recommendation, as she almost always does.

Pfizer’s two-dose mRNA vaccine is the only COVID-19 vaccine currently approved for use in children between the ages of 6 and 17.

Pfizer and Moderna’s coronavirus vaccines have already been administered to children under the age of 5, and Walensky has signed off on the committee’s previous recommendation.

The Pfizer and Moderna COVID-19 vaccines will soon be available to all children, thanks to the ACIP’s announcement on Thursday.

Parents will soon have more options for vaccines for their children thanks to this recommendation, but it is unclear what impact it will have in light of the low vaccination rates, particularly among children.

A majority of adults and older children in the United States are believed to have been vaccinated against COVID-19, but only a small percentage of eligible young children can currently say the same. There are currently 29.5 per cent of children ages 5 to 11 who have received all of their recommended vaccines.

Visit The Hill for the latest news, weather, sports, and video streaming.